- ►nih.gov KN Kangelaris, S Bent, RL Nussbaum, DA … - Journal of general internal medicine, 2009 - Springer Page 1. REVIEWS Genetic Testing Before Anticoagulation? A Systematic Review
of Pharmacogenetic Dosing of Warfarin Kirsten Neudoerffer ... Cited by 9 - Related articles - All 8 versions
G Lippi, M Franchini, EJ Favaloro - Clinical Chemistry and Laboratory Medicine, 2009 - reference-global.com Oral anticoagulant therapy (OAT) based on vitamin K antagonists (VKAs; coumarin
derivatives) is the cur- rent mainstay for the prevention and long-term treat-
ment of a variety of thromboembolic disorders. Care of patients on OAT is ... Cited by 2 - Related articles - All 4 versions
G Palareti, B Cosmi - Thromb Haemost, 2009 - schattauer.de Summary Anticoagulation with vitamin K antagonists (VKAs) has been shown to be
effective in the prevention and treatment of throm- botic complications in
various clinical settings, including atrial fi- brillation (AF), venous ... Cited by 2 - Related articles - All 3 versions
RH Howland - Drug Safety, 2009 - critcaremed.org Many different types of drugs are available to treat a wide variety of
disorders. Why some patients respond to a particular drug and others do not
respond, or why some patients tolerate a drug well and others are ... Cited by 1 - Related articles - Cached - All 5 versions
- ►nursing2008.com MJ Khoury, CM McBride, SD Schully, J … - Genetics in Medicine, 2009 - journals.lww.com Muin J. Khoury, MD, PhD1,2, Colleen M. McBride, PhD3, Sheri D. Schully, PhD2,
John PA Ioannidis, MD, PhD4, W. Gregory Feero, MD, PhD3, A. Cecile JW Janssens,
PhD5, Marta Gwinn, MD, MPH1, Denise G. Simons-Morton, MD, PhD6, Jay M. ... Cited by 1 - Related articles - All 7 versions
J Lindh - diss.kib.ki.se – Whenever a theory appears to you as the only possible one, take this as a
sign that you have neither understood the theory nor the problem which it was
intended to solve. ... The aim of this thesis was to identify factors that ... Cited by 1 - Related articles
T KITS - acponline.org Warfarin pharmacogenetics has garnered particular interest because of the drug's
extraordinarily low therapeutic index; the broad range of dosing that achieves
appropriate anticoagulation in different patients; its widespread use, at ... Related articles - Cached
N Hawkins, J de Vries, P Boddington, J Kaye … - Genome, 2009 - genomics.arizona.edu Naomi Hawkins (naomi.hawkins@ethox.ox.ac.uk) Jantina de Vries (jantina@well.ox.
ac.uk) Paula Boddington (paula.boddington@ethox.ox.ac.uk) Jane Kaye
(jane.kaye@ethox.ox.ac.uk) Catherine Heeney (catherine.heeney@ethox.ox.ac.uk) Related articles - View as HTML
AHB Wu, N Babic, KTJ Yeo - Personalized Medicine, 2009 - Future Medicine Pharmacogenomics promises to improve therapeutic care by providing the right
drug and dosage to the appropriate patient. Despite widespread interest in
personalized medicine, the implementation of clinical pharmacogenomics has ... Related articles - All 3 versions
